Complementary Medicine Practice and Use of Dietary Supplements in Pediatric Cancer Patients in Croatia.
chemotherapy
children
complementary therapies
dietary supplements
herbal medicine
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
accepted:
13
10
2022
entrez:
16
11
2022
pubmed:
17
11
2022
medline:
17
11
2022
Statut:
epublish
Résumé
The use of complementary and alternative medicine (CAM) has become a customary practice among pediatric cancer patients worldwide. The frequency of its use by pediatric cancer patients in Croatia has not been previously determined. Methodology: In order to establish the frequency and detect factors affecting the use of CAM, a single-center, observational, cross-sectional study was conducted at the Children's Hospital Zagreb during a two-year period. The patients' parents and caregivers were offered an anonymous, multi-item questionnaire that collected socio-economic and clinical data, as well as details on CAM and dietary supplement practice. Results: Almost half of the participants reported CAM and more than two-thirds reported dietary supplement consumption, predominantly in the intensive phase of the treatment. Factors regarding children or parents had no effect on CAM and supplement utilization. Herbal medicine, vitamins, and minerals were among the most commonly used items. Every 10th child experienced at least one adverse event during CAM and supplement use. Awareness of the CAM and dietary supplement application in pediatric oncology patients needs to be raised due to the potential interactions with conventional treatment modalities. For this reason, it is extremely important to inform parents and caregivers of pediatric oncology patients about the use of CAM and dietary supplements to predict and mitigate the occurrence and intensity of the side effects. In the majority of our cases, the patient's guardians informed the healthcare professionals about the CAM and supplement implementation in their children, therefore, they were offered additional information about the possible negative impact of CAM and supplement use on standard medical care in a timely manner.
Identifiants
pubmed: 36381903
doi: 10.7759/cureus.30246
pmc: PMC9652699
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e30246Informations de copyright
Copyright © 2022, Kranjcec et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Exp Clin Cancer Res. 2018 Nov 1;37(1):266
pubmed: 30382874
J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52):
pubmed: 29140495
Pediatr Blood Cancer. 2008 Feb;50(2 Suppl):494-7; discussion 498
pubmed: 18064662
Cancer Control. 2002 May-Jun;9(3):236-43
pubmed: 12060821
Pediatrics. 2008 Dec;122(6):1374-86
pubmed: 19047261
Cancer Nurs. 1998 Aug;21(4):282-8
pubmed: 9691511
Med Pediatr Oncol. 1997 Mar;28(3):205-8
pubmed: 9024518
BMC Complement Altern Med. 2010 Oct 18;10:58
pubmed: 20955609
Pediatric Health Med Ther. 2019 Jan 17;10:5-11
pubmed: 30697093
Support Care Cancer. 2016 Jul;24(7):2869-75
pubmed: 26838025
Pediatrics. 2010 Apr;125(4):768-76
pubmed: 20308209
J Integr Med. 2016 Sep;14(5):374-9
pubmed: 27641608
Acta Med Acad. 2020 Dec;49(3):240-248
pubmed: 33781067
Acta Clin Croat. ;55(4):585-592
pubmed: 29117649
Eur J Pediatr. 2013 Jan;172(1):31-7
pubmed: 22991098
J Pediatr Hematol Oncol. 2013 Oct;35(7):537-42
pubmed: 24060836
Pediatr Blood Cancer. 2011 Jul 1;56(7):1088-91
pubmed: 21360653
Bull Cancer. 2019 Mar;106(3):189-200
pubmed: 30771881
Arch Intern Med. 2003 Mar 24;163(6):699-704
pubmed: 12639203
J Pediatr Oncol Nurs. 2001 Jan-Feb;18(1):16-25
pubmed: 11172406
Eur J Cancer. 2004 Sep;40(14):2041-6
pubmed: 15341976
Pediatr Blood Cancer. 2020 Jun;67 Suppl 3:e28324
pubmed: 32614139
Ir J Med Sci. 2008 Jun;177(2):147-50
pubmed: 18427878
J Glob Oncol. 2017 Dec;3(6):701-710
pubmed: 29244997
Eur J Cancer. 2008 Oct;44(15):2233-40
pubmed: 18809313